{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:20:32Z","timestamp":1795044032475,"version":"4.10.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01279-y","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:08:22Z","timestamp":1789751302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Proposal for the Use of an Innovative Two-Stage PK-Clinical Adaptive Trial in Biosimilar Product Development"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-3858","authenticated-orcid":false,"given":"Weijia","family":"Mai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-2757","authenticated-orcid":false,"given":"Shein-Chung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"1279_CR1","unstructured":"Food and Drug Administration. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products\u2014general considerations. Food and Drug Administration. 2003."},{"key":"1279_CR2","unstructured":"FDA (2021, August). Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA Guidance for Industry. U.S. Food and Drug Administration, Silver Spring, MD."},{"key":"1279_CR3","unstructured":"FDA (2015, April). Scientific Considerations in Demonstrating Biosimilarity to a Reference Product Guidance for Industry. U.S. Food and Drug Administration, Silver Spring, MD."},{"key":"1279_CR4","unstructured":"FDA. (2022, Dec 13). Biosimilars: Overview for Health Care Professionals. https:\/\/www.fda.gov\/drugs\/biosimilars\/overview-health-care-professionals"},{"key":"1279_CR5","unstructured":"FDA. (2022, Dec 13). Biosimilars: Review and Approval. https:\/\/www.fda.gov\/drugs\/biosimilars\/review-and-approval#data"},{"key":"1279_CR6","unstructured":"FDA. (2022, Sep 19). Increasing the efficiency of biosimilar development programs [Conference session]. FDA Workshop, Silver Spring, MD, United States. https:\/\/www.fda.gov\/media\/163283\/download?attachment"},{"key":"1279_CR7","doi-asserted-by":"publisher","DOI":"10.1201\/b15303","volume-title":"Biosimilars: Design and analysis of follow-on biologics","author":"SC Chow","year":"2013","unstructured":"Chow SC. Biosimilars: Design and analysis of follow-on biologics. New York: Chapman and Hall\/CRC, Taylor and Francis; 2013."},{"key":"1279_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2024.2330204","author":"W Mai","year":"2024","unstructured":"Mai W, Chow SC. Analysis of innovative two-stage seamless adaptive design with different endpoints and population shift. J Biopharm Stat. 2024. https:\/\/doi.org\/10.1080\/10543406.2024.2330204.","journal-title":"J Biopharm Stat"},{"issue":"12","key":"1279_CR9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/sim.1177","volume":"21","author":"J Shao","year":"2002","unstructured":"Shao J, Chow SC. Reproducibility probability in clinical trials. Stat Med. 2002;21(12):1727\u201342. https:\/\/doi.org\/10.1002\/sim.1177.","journal-title":"Stat Med"},{"issue":"4","key":"1279_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2307\/2527652","volume":"15","author":"FA Graybill","year":"1959","unstructured":"Graybill FA, Deal RB. Combining unbiased estimators. Biometrics. 1959;15(4):543\u201350. https:\/\/doi.org\/10.2307\/2527652.","journal-title":"Biometrics"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01279-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01279-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01279-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:14:47Z","timestamp":1795043687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01279-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01279-y","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"151"}}